Cite
HARVARD Citation
Akdag Cayli, Y. et al. (2017). Dry powders for the inhalation of ciprofloxacin or levofloxacin combined with a mucolytic agent for cystic fibrosis patients. Drug development and industrial pharmacy. pp. 1378-1389. [Online].